Search results

Evidence-based recommendations on prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia. This involves positioning a temporary implant in the urethra to increase the flow of urine.

Result type

HealthTech guidance

Published

21 September 2022

stress urinary incontinence 1 This decision aid is for women who have complications caused by pelvic mesh that was used to treat their...

Evidence-based recommendations on transurethral water-jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia. This involves injecting a high-speed jet of water into the prostate to destroy some of the prostate tissue and widen the urethra.

Result type

HealthTech guidance

Published

14 September 2023

Summary of the evidence on antimicrobial prescribing: imipenem with cilastatin and relebactam

Result type

Evidence summary

Published

28 October 2020

Evidence-based recommendations on fetal vesico–amniotic shunt for lower urinary tract outflow obstruction. This involves inserting a cannula through the mother's abdominal and uterine walls into the amniotic cavity and subsequently into the bladder of the fetus.

Result type

HealthTech guidance

Published

13 December 2006

Evidence-based recommendations on intramural urethral bulking procedures for stress urinary incontinence in women. Intramural urethral bulking aims to augment the urethral wall and increase the urethral closure force.

Result type

HealthTech guidance

Published

23 November 2005

Evidence-based recommendations on ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections.

Result type

Antimicrobial resistance guidance

Published

17 August 2022

Evidence-based recommendations on prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia in adults. This involves blocking the blood vessels supplying the prostate with tiny plastic particles.

Result type

HealthTech guidance

Published

25 April 2018

This guideline covers preventing bacterial infection in healthy babies of up to and including 28 days corrected gestational age, treating pregnant women whose unborn baby is at risk of infection, and caring for babies of up to and including 28 days corrected gestational age with a suspected or confirmed bacterial infection. It aims to reduce delays in recognising and treating infection and prevent unnecessary use of antibiotics. The guideline does not cover viral infections.

Result type

NICE guideline

Last updated

19 March 2024

Summary of the evidence on antimicrobial prescribing of meropenem with vaborbactam (Vaborem) to inform local NHS planning and decision making

Result type

Evidence summary

Published

20 November 2019

Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia.

Result type

HealthTech guidance

Published

4 May 2021

your mesh was for stress urinary incontinence, see NICE's decision aid on treating complications from mesh used for stress...

Evidence-based recommendations on cefiderocol for treating severe drug-resistant gram-negative bacterial infections.

Result type

Antimicrobial resistance guidance

Published

17 August 2022

This guideline sets out an antimicrobial prescribing strategy for managing Clostridioides difficile infection in adults, young people and children aged 72 hours and over in community and hospital settings. It aims to optimise antibiotic use and reduce antibiotic resistance. The recommendations do not cover diagnosis.

Result type

Antimicrobial prescribing guideline

Published

23 July 2021

Evidence-based recommendations on retrograde uretral sphincterometry. This involves passing fluid through a small, cone-shaped device placed into the urethra to display the pressure needed to open the urethra sphincter.

Result type

HealthTech guidance

Published

26 April 2006